Found 5 matching trials
Efficacy and Safety of VAH as a Bridging Regimen to Allo-HCT in Relapsed/Refractory AML
PHASE2Allogeneic hematopoietic cell transplantation (allo-HCT) is the only treatm...
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Venetoclax and Azacitidine Combined With Homoharringtonine, Followed by Allo-HSCT for Intermediate and High-risk AML.
PHASE2This study is a single-center, single-arm, prospective phase II clinical tr...
Location
Shanghai General hospital,Shanghai Jiao Tong University School of Medicine
Influence of Molecular Abnormalities on Response of VAH vs. VEN+HMA in RR-AML
N/AThe aim of this study is to reveal the influence of gene mutations on the t...
Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Chidamide, Venetoclax, Azacitidine, and Homoharringtonine for High-risk Fit AML
PHASE2This study aims to explore a superior first-line induction remission regime...
Location
Multiple Locations
VAH Versus VA for Salvage Therapy of R/R-AML
PHASE3This is a prospective, multi-center, phase 3 randomized controlled clinical...
Location
Department of Hematology,Nanfang Hospital, Southern Medical University